Arsenault Kaitlyn

Chief Financial Officer at SKYE

Sold, on record
$217k
Dollars the filings state
Form 4 sales
1
Latest Nov 18, 2024
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • SKYESkye Bioscience, Inc.Chief Financial Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Timeline

  1. 1 Form 144 notice SKYENotice
    Nov 15, 2024 2024

    Filed to sell 57,084 shares ($315k)

    Arsenault Kaitlyn, Officer

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale SKYENo plan
    Nov 18, 2024 +3 days

    Sold 43,396 shares at $4.99 ($217k)

    Arsenault Kaitlyn, Chief Financial Officer

    No 10b5-1 planSold 20.7% of holdings ($1M position)166,342 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Arsenault Kaitlyn
Source
Nov 18, 2024Nov 19, 2024SKYEChief Financial OfficerForm 4 sale43,396$217k20.7%No planSEC
Nov 15, 2024Nov 15, 2024SKYEOfficerForm 144 notice57,084$315kNoticeSEC